Medically reviewed by Drugs.com. Last updated on Jan 21, 2021.
Generic name: CABOTEGRAVIR SODIUM 30mg
Dosage form: tablet, film coated
Oral Lead-in Dosing to Assess Tolerability of Cabotegravir
Consult the prescribing information for CABENUVA (cabotegravir; rilpivirine) extended-release injectable suspension before initiating VOCABRIA to ensure therapy with CABENUVA is appropriate. See full prescribing information for CABENUVA.
Oral lead-in should be used for approximately 1 month (at least 28 days) to assess the tolerability of cabotegravir prior to the initiation of CABENUVA. The recommended oral daily dose is one 30-mg tablet of VOCABRIA in combination with one 25-mg tablet of EDURANT (rilpivirine). The last oral dose should be taken on the same day injections with CABENUVA are started.
Take VOCABRIA once daily with EDURANT at approximately the same time each day with a meal [see Clinical Pharmacology (12.3)].
Because VOCABRIA is indicated in combination with rilpivirine tablets, the prescribing information for EDURANT should also be consulted.
Oral Dosing to Replace Planned Missed Injections of CABENUVA (Up to 2 Consecutive Monthly Injections)
If a patient plans to miss a scheduled injection of CABENUVA (cabotegravir; rilpivirine) extended-release injectable suspensions by more than 7 days, take daily oral therapy to replace up to 2 consecutive monthly injection visits. The recommended oral daily dose is one 30-mg tablet of VOCABRIA (cabotegravir) and one 25-mg tablet of EDURANT (rilpivirine). Take VOCABRIA with EDURANT at approximately the same time each day with a meal. The first dose of oral therapy should be taken approximately 1 month after the last injection dose of CABENUVA and continued until the day injection dosing is restarted. See full prescribing information for CABENUVA to resume monthly injection dosing.
More about Vocabria (cabotegravir)
- Drug Images
- Drug Interactions
- En Español
- Drug class: integrase strand transfer inhibitor
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.